Prevalence of Potential Drug–Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors

Elisabeth Deutschmann, Heiner C. Bucher, Steffen Jaeckel, Sara Gibbons, Katie McAllister, Alexandra Scherrer, Dominique L. Braun, Matthias Cavassini, Anna Hachfeld, Alexandra Calmy, Manuel Battegay, Michela Cipriani, Luigia Elzi, Jim Young, Beatriz López Centeno, Juan Berenguer, Saye Khoo, Giusi Moffa, Catia Marzolini, Swiss Hiv Cohort StudyClinical 2020 · DOI

Abstract

Prevalence of PDDIs was lower with more widespread use of INIs in 2018 than in 2008. Continued use of boosted regimens and increasing needs for co-medications in this aging population impeded lower rates of PDDIs.
BibTeX
@inproceedings{deutschmann2020prevalence,
  author = {Elisabeth Deutschmann and Heiner C. Bucher and Steffen Jaeckel and Sara Gibbons and Katie McAllister and Alexandra Scherrer and Dominique L. Braun and Matthias Cavassini and Anna Hachfeld and Alexandra Calmy and Manuel Battegay and Michela Cipriani and Luigia Elzi and Jim Young and Beatriz López Centeno and Juan Berenguer and Saye Khoo and Giusi Moffa and Catia Marzolini and Swiss HIV Cohort Study},
  title = {{Prevalence of Potential Drug–Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors}},
  booktitle = {Clinical},
  year = {2020},
  doi = {10.1093/cid/ciaa918},
}

Loading related content...

Figure